Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""cross protection"" wg kryterium: Temat


Tytuł :
Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.
Autorzy :
Chakrabarti S; Department of Biochemistry and Central Research Cell, Maharishi Markandeshwar (Deemed to be) University, Mullana, Haryana, India.
Chakrabarti SS; Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Kaur U; Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Agrawal BK; Department of Medicine, Maharishi Markandeshwar (Deemed to be) University, Mullana, Haryana, India.
Ganguly U; Department of Biochemistry and Central Research Cell, Maharishi Markandeshwar (Deemed to be) University, Mullana, Haryana, India.
Jin K; Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Jul; Vol. 93 (7), pp. 4094-4096. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Letter
MeSH Terms :
Cross Protection*
COVID-19/*immunology
COVID-19/*mortality
Animals ; Humans ; Immune Tolerance ; Immunity, Heterologous ; Immunity, Innate ; Immunologic Memory ; Pandemics
Opinia redakcyjna
Tytuł :
Background immunity: How important is it for SARS-CoV-2?
Autorzy :
Silva Júnior JVJ; Virology Sector, Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Pernambuco, Brazil.; Department of Microbiology and Parasitology, Federal University of Santa Maria, Santa Maria, Brazil.; Virology Sector, Department of Preventive Veterinary Medicine, Federal University of Santa Maria, Santa Maria, Brazil.
Lopes TRR; Virology Sector, Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Pernambuco, Brazil.; Virology Sector, Department of Preventive Veterinary Medicine, Federal University of Santa Maria, Santa Maria, Brazil.
Weiblen R; Virology Sector, Department of Preventive Veterinary Medicine, Federal University of Santa Maria, Santa Maria, Brazil.
Flores EF; Virology Sector, Department of Preventive Veterinary Medicine, Federal University of Santa Maria, Santa Maria, Brazil.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Mar; Vol. 93 (3), pp. 1253-1254. Date of Electronic Publication: 2020 Nov 01.
Typ publikacji :
Letter
MeSH Terms :
Cross Protection*
Immunity, Innate*
Social Determinants of Health*
COVID-19/*immunology
COVID-19/*prevention & control
Antibodies, Viral ; BCG Vaccine/immunology ; Host Microbial Interactions ; Humans ; Hygiene Hypothesis
Opinia redakcyjna
Tytuł :
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Autorzy :
Choi JA; Science Unit, International Vaccine Institute, Seoul, South Korea.
Goo J; Science Unit, International Vaccine Institute, Seoul, South Korea.
Yang E; Science Unit, International Vaccine Institute, Seoul, South Korea.
Jung DI; Science Unit, International Vaccine Institute, Seoul, South Korea.
Lee S; Science Unit, International Vaccine Institute, Seoul, South Korea.
Rho S; Science Unit, International Vaccine Institute, Seoul, South Korea.
Jeong Y; Science Unit, International Vaccine Institute, Seoul, South Korea.
Park YS; Science Unit, International Vaccine Institute, Seoul, South Korea.
Park H; Science Unit, International Vaccine Institute, Seoul, South Korea.
Moon YH; Science Unit, International Vaccine Institute, Seoul, South Korea.
Park U; Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.
Seo SH; Science Unit, International Vaccine Institute, Seoul, South Korea.
Lee H; NKMAX Co., Ltd., Sungnam, South Korea.
Lee JM; Department of Microbiology and Immunology, Graduate School of Medical Science, Brain Korea 21 Project, Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, South Korea.
Cho NH; Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.
Song M; Science Unit, International Vaccine Institute, Seoul, South Korea .
Kim JO; Science Unit, International Vaccine Institute, Seoul, South Korea .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Nov 23; Vol. 94 (24). Date of Electronic Publication: 2020 Nov 23 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cross Protection*
Coronavirus Infections/*immunology
Coronavirus Infections/*prevention & control
Middle East Respiratory Syndrome Coronavirus/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Vaccines, DNA/*immunology
Viral Vaccines/*immunology
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Coronavirus Infections/mortality ; Coronavirus Infections/virology ; Disease Models, Animal ; Female ; Humans ; Immunity, Cellular ; Immunization, Secondary ; Immunogenicity, Vaccine ; Mice ; Plasmids/administration & dosage ; Plasmids/genetics ; Plasmids/immunology ; Spike Glycoprotein, Coronavirus/genetics ; Vaccination ; Vaccines, DNA/administration & dosage ; Viral Vaccines/administration & dosage
Czasopismo naukowe
Tytuł :
Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.
Autorzy :
Yaqinuddin A; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. Electronic address: .
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2020 Nov; Vol. 144, pp. 110049. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
SARS-CoV-2*
COVID-19/*immunology
COVID-19/*mortality
Adaptive Immunity ; Antigens/immunology ; Apoptosis ; Coronavirus Infections/immunology ; Coronavirus Infections/mortality ; Cross Reactions ; Disease Outbreaks ; Epitopes, B-Lymphocyte/chemistry ; Epitopes, T-Lymphocyte/chemistry ; Humans ; Immune System ; Immunity ; Middle East Respiratory Syndrome Coronavirus ; SARS Virus ; Severe Acute Respiratory Syndrome/immunology ; Severe Acute Respiratory Syndrome/mortality
Czasopismo naukowe
Tytuł :
T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.
Autorzy :
Wang R; Beijing Key Laboratory of Pediatric Respiratory Infection diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, 100045, China.; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Zhen Z; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Turtle L; National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, L69 7BE, UK.; Tropical and Infectious Disease Unit, Liverpool University Hospitals Foundation Trust (Member of Liverpool Health Partners), Liverpool, L7 8XP, UK.
Hou B; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Li Y; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Wu N; Laboratory Animal Center, Capital Medical University, Beijing, 100069, China.
Gao N; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Fan D; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Chen H; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China. .
An J; Department of Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.; Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, 100069, China.
Pokaż więcej
Źródło :
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2020 Aug; Vol. 104 (15), pp. 6779-6789. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Antibodies, Viral/*blood
Japanese Encephalitis Vaccines/*immunology
T-Lymphocytes/*immunology
Zika Virus Infection/*immunology
Zika Virus Infection/*prevention & control
Animals ; Antibodies, Neutralizing/blood ; Antibody-Dependent Enhancement ; China ; Cross Reactions ; Encephalitis, Japanese/prevention & control ; Female ; Japanese Encephalitis Vaccines/administration & dosage ; Male ; Mice ; Mice, Inbred C57BL ; Specific Pathogen-Free Organisms ; Th1 Cells/immunology ; Th2 Cells/immunology ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/immunology
Czasopismo naukowe
Tytuł :
Limited Cross-Protection Provided by Prior Infection Contributes to High Prevalence of Influenza D Viruses in Cattle.
Autorzy :
Wan XF; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA .; Department of Electrical Engineering & Computer Science, College of Engineering, University of Missouri, Columbia, Missouri, USA.; Missouri University Center for Research on Influenza Systems Biology (CRISB), University of Missouri, Columbia, Missouri, USA.; Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.; MU Informatics Institute, University of Missouri, Columbia, Missouri, USA.; Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
Ferguson L; Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
Oliva J; IHAP, University of Toulouse, INRA, ENVT, Toulouse, France.
Rubrum A; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Eckard L; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Zhang X; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.; Missouri University Center for Research on Influenza Systems Biology (CRISB), University of Missouri, Columbia, Missouri, USA.; Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
Woolums AR; Department of Population and Pathobiology Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
Lion A; IHAP, University of Toulouse, INRA, ENVT, Toulouse, France.
Meyer G; IHAP, University of Toulouse, INRA, ENVT, Toulouse, France.
Murakami S; Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Ma W; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.
Horimoto T; Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Webby R; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Ducatez MF; IHAP, University of Toulouse, INRA, ENVT, Toulouse, France.
Epperson W; Department of Population and Pathobiology Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Aug 31; Vol. 94 (18). Date of Electronic Publication: 2020 Aug 31 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cross Protection*
Genome, Viral*
Antibodies, Viral/*blood
Orthomyxoviridae Infections/*epidemiology
Reassortant Viruses/*immunology
Thogotovirus/*immunology
Animals ; Cattle ; Epidemiological Monitoring ; Farms ; Genetic Variation ; Genotype ; Hospitals, Animal ; Immunity, Innate ; Mice ; Mississippi/epidemiology ; Molecular Typing ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/virology ; Phylogeny ; Reassortant Viruses/classification ; Reassortant Viruses/genetics ; Reassortant Viruses/pathogenicity ; Seroepidemiologic Studies ; Thogotovirus/classification ; Thogotovirus/genetics ; Thogotovirus/pathogenicity ; Virus Replication
Czasopismo naukowe
Tytuł :
Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC).
Autorzy :
Hu R; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
Li J; Department of Animal Engineering, Yangling Vocation and Technical College, Yangling, 712100, Shaanxi, China.
Zhao Y; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
Lin H; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
Liang L; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
Wang M; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
Liu H; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
Min Y; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
Gao Y; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China. .
Yang M; College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China. .
Pokaż więcej
Źródło :
Microbial cell factories [Microb Cell Fact] 2020 Jun 03; Vol. 19 (1), pp. 119. Date of Electronic Publication: 2020 Jun 03.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Antigens, Bacterial/*immunology
Bacterial Outer Membrane/*immunology
Bacterial Outer Membrane Proteins/*immunology
Chickens/*immunology
Escherichia coli Vaccines/*immunology
Poultry Diseases/*prevention & control
Animals ; Antibodies, Bacterial/immunology ; Cytokines/immunology ; Escherichia coli/immunology ; Macrophages/immunology
Czasopismo naukowe
Tytuł :
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
Autorzy :
Mishra N; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery Group, Leuven, Belgium.
Boudewijns R; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery Group, Leuven, Belgium.
Schmid MA; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery Group, Leuven, Belgium.
Marques RE; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery Group, Leuven, Belgium.
Sharma S; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery Group, Leuven, Belgium.
Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery Group, Leuven, Belgium .
Dallmeier K; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery Group, Leuven, Belgium .
Pokaż więcej
Źródło :
MBio [mBio] 2020 Apr 07; Vol. 11 (2). Date of Electronic Publication: 2020 Apr 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cross Protection*
Antibodies, Viral/*blood
Japanese Encephalitis Vaccines/*genetics
Japanese Encephalitis Vaccines/*immunology
T-Lymphocytes/*immunology
Yellow Fever/*prevention & control
Animals ; Antibodies, Neutralizing ; HEK293 Cells ; Humans ; Male ; Mice ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/immunology ; Viral Nonstructural Proteins/immunology ; Yellow Fever/immunology ; Yellow fever virus
Czasopismo naukowe
Tytuł :
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
Autorzy :
Shaw RH; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
Stuart A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
Van-Tam JSN; Division of Epidemiology and Public Health, School of Clinical Sciences, University of Nottingham, Nottingham, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: .
Pokaż więcej
Corporate Authors :
Com-COV Study Group
Źródło :
Lancet (London, England) [Lancet] 2021 May 29; Vol. 397 (10289), pp. 2043-2046. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects
COVID-19 Vaccines/*immunology
Immunization, Secondary/*methods
Mass Vaccination/*methods
COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; Cross Protection/immunology ; Humans ; Immunity, Heterologous ; Immunization, Secondary/adverse effects ; Immunogenicity, Vaccine ; Mass Vaccination/adverse effects ; SARS-CoV-2/immunology
Raport
Tytuł :
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
Autorzy :
Anderson EM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Goodwin EC; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Verma A; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Arevalo CP; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Bolton MJ; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Weirick ME; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Gouma S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
McAllister CM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Christensen SR; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Weaver J; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Hicks P; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Manzoni TB; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Oniyide O; Division of Pulmonary, Allergy, and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Ramage H; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Mathew D; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Baxter AE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Oldridge DA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Greenplate AR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Wu JE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Alanio C; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
D'Andrea K; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kuthuru O; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Dougherty J; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pattekar A; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kim J; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Han N; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Apostolidis SA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Huang AC; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Vella LA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Kuri-Cervantes L; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pampena MB; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Betts MR; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Meyer NJ; Division of Pulmonary, Allergy, and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Cherry S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Bates P; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA 19104, USA.
Rader DJ; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Hensley SE; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: .
Pokaż więcej
Corporate Authors :
UPenn COVID Processing Unit
Źródło :
Cell [Cell] 2021 Apr 01; Vol. 184 (7), pp. 1858-1864.e10. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Viral*/blood
Antibodies, Viral*/immunology
Alphacoronavirus/*immunology
Betacoronavirus/*immunology
COVID-19/*immunology
Adolescent ; Adult ; Animals ; COVID-19 Serological Testing ; Child ; Child, Preschool ; Chlorocebus aethiops ; Cross Protection ; Cross Reactions ; Disease Susceptibility ; HEK293 Cells ; Humans ; Infant ; Infant, Newborn ; Vero Cells
Czasopismo naukowe
Tytuł :
SipD and IpaD induce a cross-protection against Shigella and Salmonella infections.
Autorzy :
Jneid B; Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Gif-sur-Yvette, France.
Rouaix A; Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Gif-sur-Yvette, France.
Féraudet-Tarisse C; Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Gif-sur-Yvette, France.
Simon S; Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Gif-sur-Yvette, France.
Pokaż więcej
Źródło :
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 May 28; Vol. 14 (5), pp. e0008326. Date of Electronic Publication: 2020 May 28 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cross Protection*
Antigens, Bacterial/*immunology
Bacterial Proteins/*immunology
Dysentery, Bacillary/*prevention & control
Membrane Proteins/*immunology
Salmonella Infections/*prevention & control
Salmonella Vaccines/*immunology
Shigella Vaccines/*immunology
Administration, Intranasal ; Administration, Oral ; Animals ; Antibodies, Bacterial/analysis ; Disease Models, Animal ; Female ; Immunoglobulin A/analysis ; Immunoglobulin G/analysis ; Mice, Inbred BALB C ; Salmonella Vaccines/administration & dosage ; Salmonella typhimurium/immunology ; Shigella Vaccines/administration & dosage ; Shigella flexneri/immunology ; Survival Analysis
Czasopismo naukowe
Tytuł :
Coronavirus – cross-immunity, herd immunity and vaccine development.
Autorzy :
Munthe LA
Pokaż więcej
Transliterated Title :
Koronaviruset – kryssimmunitet, flokkimmunitet og vaksineutvikling.
Źródło :
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2020 Apr 08; Vol. 140 (7). Date of Electronic Publication: 2020 Apr 08 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Immunity, Herd*
COVID-19/*immunology
COVID-19 Vaccines/*immunology
Humans
Czasopismo naukowe
Tytuł :
Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
Autorzy :
Zhou Y; Institute of Arboviruses, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
Chen D; Institute of Arboviruses, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China; The Sixth People's Hospital of Wenzhou, Wenzhou, Zhejiang, 325000, China.
Yang L; Institute of Arboviruses, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
Zou W; Institute of Arboviruses, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
Duan Z; Department of Clinical Laboratory, the Second Hospital of Ningbo, Ningbo, Zhejiang, 315000, China.
Zhang Y; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, China. Electronic address: .
Wen J; Institute of Arboviruses, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China; Department of Microbiology, Ningbo University School of Medicine, Ningbo, Zhejiang, 315211, China. Electronic address: .
Pokaż więcej
Źródło :
Virus research [Virus Res] 2020 Mar; Vol. 278, pp. 197882. Date of Electronic Publication: 2020 Jan 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cross Protection*
Immunization, Passive*
Antibodies, Viral/*immunology
Viral Envelope Proteins/*immunology
Zika Virus Infection/*prevention & control
Animals ; Animals, Newborn/immunology ; Animals, Newborn/virology ; Antibodies, Neutralizing/immunology ; Chlorocebus aethiops ; Dengue Virus/immunology ; Disease Models, Animal ; Female ; Immunity, Maternally-Acquired ; Immunization ; Male ; Mice ; Mice, Inbred C57BL ; Neutralization Tests ; Protein Domains/immunology ; Vero Cells ; Zika Virus/immunology ; Zika Virus Infection/immunology
Czasopismo naukowe
Tytuł :
A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.
Autorzy :
Bouvet J; Boehringer Ingelheim Animal Health, Centre de Recherche de Saint-Vulbas, Parc Industriel de la Plaine de l'Ain, 805 Allée des Cyprès, 01150 Saint-Vulbas, France. Electronic address: .
Lemaitre L; Boehringer Ingelheim Animal Health, Centre de Recherche de Saint-Vulbas, Parc Industriel de la Plaine de l'Ain, 805 Allée des Cyprès, 01150 Saint-Vulbas, France.
Cariou C; Boehringer Ingelheim Animal Health, Lyon Porte des Alpes, rue de l'aviation, 69800 Saint-Priest, France.
Scotto M; Boehringer Ingelheim Animal Health, Centre de Recherche de Saint-Vulbas, Parc Industriel de la Plaine de l'Ain, 805 Allée des Cyprès, 01150 Saint-Vulbas, France.
Blain C; Boehringer Ingelheim Animal Health, Lyon Porte des Alpes, rue de l'aviation, 69800 Saint-Priest, France.
Oberli F; Boehringer Ingelheim Animal Health, Centre de Recherche de Saint-Vulbas, Parc Industriel de la Plaine de l'Ain, 805 Allée des Cyprès, 01150 Saint-Vulbas, France.
Cupillard L; Boehringer Ingelheim Animal Health, Lyon Porte des Alpes, rue de l'aviation, 69800 Saint-Priest, France.
Guigal PM; Boehringer Ingelheim Animal Health, Centre de Recherche de Saint-Vulbas, Parc Industriel de la Plaine de l'Ain, 805 Allée des Cyprès, 01150 Saint-Vulbas, France.
Pokaż więcej
Źródło :
Veterinary immunology and immunopathology [Vet Immunol Immunopathol] 2020 Jan; Vol. 219, pp. 109985. Date of Electronic Publication: 2019 Nov 15.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Bacterial Vaccines/*immunology
Dog Diseases/*prevention & control
Leptospira interrogans/*immunology
Leptospirosis/*veterinary
Vaccination/*veterinary
Animals ; Antibodies, Bacterial/blood ; Bacterial Vaccines/administration & dosage ; Dog Diseases/microbiology ; Dogs ; Leptospira interrogans/classification ; Leptospirosis/prevention & control ; Serogroup
Czasopismo naukowe
Tytuł :
Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs.
Autorzy :
Grodeland G; K.G. Jebsen Centre of Influenza Vaccine Research, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, N-0027 Oslo, Norway. Electronic address: .
Fossum E; K.G. Jebsen Centre of Influenza Vaccine Research, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, N-0027 Oslo, Norway.
Bogen B; K.G. Jebsen Centre of Influenza Vaccine Research, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, N-0027 Oslo, Norway.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2020 Feb 05; Vol. 38 (6), pp. 1280-1285. Date of Electronic Publication: 2019 Dec 10.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Orthomyxoviridae Infections*/prevention & control
Orthomyxoviridae Infections*/veterinary
Hemagglutinin Glycoproteins, Influenza Virus/*immunology
Influenza Vaccines/*immunology
Receptors, Chemokine/*immunology
T-Lymphocytes/*immunology
Animals ; Antibodies, Viral/immunology ; Antigen-Presenting Cells/immunology ; Swine ; Vaccines, DNA/immunology
Czasopismo naukowe
Tytuł :
Modification of neutralizing epitopes of hemagglutinin for the development of broadly protective H9N2 vaccine.
Autorzy :
Poh ZW; Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.
Wang Z; Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.
Kumar SR; Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.
Yong HY; Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.
Prabakaran M; Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2020 Feb 05; Vol. 38 (6), pp. 1286-1290. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cross Protection*
Influenza A Virus, H9N2 Subtype*/genetics
Influenza A Virus, H9N2 Subtype*/immunology
Epitopes/*immunology
Hemagglutinin Glycoproteins, Influenza Virus/*immunology
Influenza Vaccines/*immunology
Influenza in Birds/*prevention & control
Animals ; Antibodies, Viral/immunology ; Chickens ; Epitopes/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Influenza Vaccines/genetics ; Mice ; Mutation ; Orthomyxoviridae Infections/prevention & control
Czasopismo naukowe
Tytuł :
Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
Autorzy :
Wang Q; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention & Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, Taian, 271018, PR China; Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, 430072, PR China.
Fu T; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention & Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, Taian, 271018, PR China; Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao, 272000, PR China.
Li X; East China Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Shanghai, 200090, PR China.
Luo Q; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention & Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, Taian, 271018, PR China.
Huang J; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention & Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, Taian, 271018, PR China.
Sun Y; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention & Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, Taian, 271018, PR China.
Wang X; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention & Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, Taian, 271018, PR China; Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao, 272000, PR China. Electronic address: .
Pokaż więcej
Źródło :
Fish & shellfish immunology [Fish Shellfish Immunol] 2020 Feb; Vol. 97, pp. 382-389. Date of Electronic Publication: 2019 Dec 10.
Typ publikacji :
Journal Article
MeSH Terms :
Cichlids*
Cross Protection*
Fish Diseases/*prevention & control
Streptococcal Vaccines/*pharmacology
Streptococcus agalactiae/*immunology
Streptococcus iniae/*immunology
Vaccination/*veterinary
Animals ; Antibodies, Bacterial/blood ; Immunity, Humoral ; Immunity, Innate ; Streptococcal Infections/prevention & control ; Streptococcal Infections/veterinary ; Streptococcal Vaccines/administration & dosage ; Streptococcal Vaccines/classification
Czasopismo naukowe
Tytuł :
Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
Autorzy :
Servat A; French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Nancy Laboratory for Rabies and Wildlife, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, Technopôle Agricole et Vétérinaire, Domaine de Pixérécourt, CS 40009, 54220 Malzéville, France. .
Wasniewski M; French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Nancy Laboratory for Rabies and Wildlife, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, Technopôle Agricole et Vétérinaire, Domaine de Pixérécourt, CS 40009, 54220 Malzéville, France. .
Cliquet F; French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Nancy Laboratory for Rabies and Wildlife, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, Technopôle Agricole et Vétérinaire, Domaine de Pixérécourt, CS 40009, 54220 Malzéville, France. .
Pokaż więcej
Źródło :
Viruses [Viruses] 2019 Oct 11; Vol. 11 (10). Date of Electronic Publication: 2019 Oct 11.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Rabies Vaccines*
Vaccines, Inactivated*
Lyssavirus/*immunology
Rhabdoviridae Infections/*prevention & control
Vaccination/*veterinary
Animals ; Antibodies, Neutralizing ; Antibodies, Viral ; Chiroptera/virology ; Europe/epidemiology ; Mice ; Rabies/veterinary ; Rhabdoviridae Infections/veterinary
SCR Organism :
European bat 1 lyssavirus
Czasopismo naukowe
Tytuł :
Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
Autorzy :
Wang W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. .
Huang B; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Wang X; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Tan W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Ruan L; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. .
Pokaż więcej
Źródło :
Virologica Sinica [Virol Sin] 2019 Oct; Vol. 34 (5), pp. 583-591. Date of Electronic Publication: 2019 Jun 25.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Influenza A Virus, H3N2 Subtype/*immunology
Influenza Vaccines/*immunology
Influenza, Human/*prevention & control
Nucleoproteins/*immunology
Vaccinia/*genetics
Viral Matrix Proteins/*immunology
Animals ; Antibodies, Viral/blood ; Female ; Humans ; Immunity, Cellular ; Immunity, Humoral ; Immunization ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza Vaccines/genetics ; Mice, Inbred BALB C ; Nucleoproteins/genetics ; Orthomyxoviridae Infections/prevention & control ; Specific Pathogen-Free Organisms ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/immunology ; Viral Matrix Proteins/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies